FLGC official logo FLGC
FLGC 1-star rating from Upturn Advisory
Flora Growth Corp (FLGC) company logo

Flora Growth Corp (FLGC)

Flora Growth Corp (FLGC) 1-star rating from Upturn Advisory
$8.95
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

01/28/2026: FLGC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

2 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $30

1 Year Target Price $30

Analysts Price Target For last 52 week
$30 Target price
52w Low $5.86
Current$8.95
52w High $47
Advertisement

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 5.81M USD
Price to earnings Ratio -
1Y Target Price 30
Price to earnings Ratio -
1Y Target Price 30
Volume (30-day avg) 2
Beta 1.87
52 Weeks Range 5.86 - 47.00
Updated Date 01/31/2026
52 Weeks Range 5.86 - 47.00
Updated Date 01/31/2026
Dividends yield (FY) -
Basic EPS (TTM) -41.09

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Revenue by Geography

Geography revenue - Year on Year

Advertisement

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -27.7%
Operating Margin (TTM) -33.5%

Management Effectiveness

Return on Assets (TTM) -17.55%
Return on Equity (TTM) -45.26%

Valuation

Trailing PE -
Forward PE 7.89
Enterprise Value 19146760
Price to Sales(TTM) 0.37
Enterprise Value 19146760
Price to Sales(TTM) 0.37
Enterprise Value to Revenue 0.37
Enterprise Value to EBITDA -1
Shares Outstanding 741261
Shares Floating 613514
Shares Outstanding 741261
Shares Floating 613514
Percent Insiders 16.61
Percent Institutions 2.05

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Flora Growth Corp

Flora Growth Corp(FLGC) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Flora Growth Corp. was founded in 2019 with the vision of becoming a leading global indoor cannabis cultivator. Its primary focus has been on developing and operating state-of-the-art, sustainable indoor cultivation facilities in North America. A significant milestone was its public listing on the Nasdaq stock exchange, providing capital for expansion. The company has evolved by expanding its product offerings beyond raw cannabis to include derivatives and wellness products.

Company business area logo Core Business Areas

  • Cannabis Cultivation and Production: Flora Growth Corp. operates high-tech, controlled-environment agriculture (CEA) facilities designed for the sustainable and efficient cultivation of high-quality cannabis. This segment focuses on producing biomass for various applications and developing proprietary cultivation methods.
  • Cannabis Derivatives and Finished Products: This segment involves the extraction of cannabinoids from cultivated cannabis and their incorporation into a range of finished products. This includes oils, tinctures, and potentially other consumer goods leveraging the therapeutic and wellness properties of cannabis compounds.
  • E-commerce and Direct-to-Consumer (DTC): Flora Growth Corp. aims to leverage e-commerce platforms to reach consumers directly with its product offerings. This strategy allows for greater control over brand messaging and customer relationships.

leadership logo Leadership and Structure

Flora Growth Corp. is led by a management team with experience in cultivation, biotechnology, and business development. The organizational structure is designed to support its cultivation operations, product development, and market expansion strategies. Specific leadership details (CEO, CFO, etc.) and their bios would typically be found in their investor relations materials.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Description: Cultivated cannabis biomass from Flora's controlled environments, intended for extraction and use in downstream products. Market share data is difficult to ascertain for this specific product category for Flora alone, as it is often an ingredient. Key competitors in cannabis cultivation include Cronos Group (CRON), Canopy Growth (WEED), Tilray (TLRY), and numerous private cultivators.
  • Product Name 1: High-Quality Cannabis Biomass
  • Description: Finished consumer products containing cannabinoids, marketed for various wellness applications. Market share in this segment is highly fragmented. Competitors include a vast array of established and emerging cannabis brands, as well as companies in the broader health and wellness sector.
  • Product Name 2: Cannabis-Derived Wellness Products (e.g., Oils, Tinctures)

Market Dynamics

industry overview logo Industry Overview

The cannabis industry is dynamic and rapidly evolving, marked by increasing legalization in various jurisdictions, growing consumer acceptance, and significant investment. Key trends include the shift towards medicinal and recreational use, development of novel product formats, and a focus on sustainable and scientific cultivation practices. Regulatory changes and market access remain critical factors.

Positioning

Flora Growth Corp. positions itself as a leader in sustainable, high-tech cannabis cultivation. Its competitive advantages lie in its proprietary cultivation technology, focus on quality control, and strategy to integrate cultivation with downstream product development and direct-to-consumer sales. The company aims to differentiate through efficiency and sustainability.

Total Addressable Market (TAM)

The global cannabis market is substantial and projected to grow significantly. While precise TAM figures vary by source and scope (e.g., including medical, recreational, CBD), estimates often range in the tens of billions of dollars, with significant expansion anticipated over the next decade. Flora Growth Corp. is positioned to capture a portion of this TAM through its cultivation and product development capabilities, particularly in markets where it has regulatory access and can leverage its efficient production model.

Upturn SWOT Analysis

Strengths

  • State-of-the-art, sustainable cultivation facilities
  • Proprietary cultivation technologies
  • Focus on quality and consistency
  • Vertical integration strategy (cultivation to product)
  • Experienced management team

Weaknesses

  • Brand recognition and market penetration challenges in a crowded market
  • Dependence on regulatory changes and market access
  • Historically high operational costs and cash burn
  • Limited historical financial track record compared to established players
  • Potential challenges in scaling production rapidly and cost-effectively

Opportunities

  • Expansion into new and emerging cannabis markets
  • Development of new cannabinoid-based wellness products
  • Strategic partnerships and acquisitions
  • Growth in the global CBD market
  • Increased consumer demand for sustainable products

Threats

  • Intensifying competition from domestic and international players
  • Unfavorable regulatory shifts or policy changes
  • Price compression due to oversupply
  • Challenges in international market entry and compliance
  • Economic downturns impacting consumer spending

Competitors and Market Share

Key competitor logo Key Competitors

  • Cronos Group (CRON)
  • Canopy Growth Corporation (WEED)
  • Tilray Brands, Inc. (TLRY)
  • Aurora Cannabis Inc. (ACB)

Competitive Landscape

Flora Growth Corp. faces a highly competitive landscape dominated by larger, more established players with greater financial resources and brand recognition. Its advantages lie in its focus on advanced cultivation technology and sustainability, which could appeal to specific market segments. However, it faces disadvantages in terms of scale, capital, and immediate market penetration compared to its larger rivals.

Growth Trajectory and Initiatives

Historical Growth: Flora Growth Corp. has demonstrated historical growth in revenue as it has brought its cultivation facilities online and expanded its product portfolio. The company has focused on building its operational capacity and market presence since its inception. Revenue growth figures would show an upward trend as operations mature.

Future Projections: Future growth projections for Flora Growth Corp. are contingent on its ability to successfully scale its operations, gain market share in its target geographies, and effectively launch new products. Analyst estimates would likely project continued revenue growth, with an eventual path towards profitability as operations become more efficient and economies of scale are realized. The company's expansion into new product categories and markets will be key drivers.

Recent Initiatives: Recent initiatives likely include the expansion of cultivation capacity, the development and launch of new consumer product lines, exploring new geographic markets, and potentially seeking strategic partnerships or acquisitions to accelerate growth and market access.

Summary

Flora Growth Corp. is an emerging player in the cannabis industry, focused on advanced cultivation and product development. The company has shown revenue growth but faces significant competition and has yet to achieve consistent profitability. Its strengths lie in its technological approach to cultivation and sustainability, while its weaknesses include brand recognition and financial scale. Continued strategic execution, market access, and efficient operations will be crucial for its future success.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company filings (SEC)
  • Industry reports
  • Financial news outlets
  • Market data providers

Disclaimers:

This JSON output is based on publicly available information and general industry knowledge as of the last update. It is not investment advice. Financial data and market share figures are estimates and subject to change. Investors should conduct their own due diligence.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Flora Growth Corp

Exchange NASDAQ
Headquaters Fort Lauderdale, FL, United States
IPO Launch date 2021-05-11
CEO & Director Mr. Daniel Reis-Faria
Sector Financial Services
Industry Asset Management
Full time employees 64
Full time employees 64

Flora Growth Corp. operates as an AI-powered asset management company focused on providing decentralized AI. In addition, it engages in the distribution of pharmaceutical goods and medical cannabis products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. Flora Growth Corp. was incorporated in 2019 and is headquartered in Fort Lauderdale, Florida.